Esther Ruescas-Escolano

Dr. Esther Ruescas-Escolano


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
NVNancy Vicente-Alcalde
Nancy Vicente-Alcalde
EREsther Ruescas-Escolano
Esther Ruescas-Escolano
Zitta F B Barrella HarboeZitta F B Barrella Harboe
Zitta F B Barrella Harboe
José TuellsJosé Tuells
José Tuells
Prison inmates are highly susceptible for several infectious diseases, including vaccine-preventable diseases. We conducted a systematic international literature review on vaccination coverage against hepatitis B virus (HBV), hepatitis A virus (HAV), combined HAV/HBV, tetanus-diphtheria, influenza, pneumococcal, and combined measles, mumps, and rubella (MMR) in prison inmates, according to the PRISMA guidelines. The electronic databases were used Web of Science, MEDLINE, Scopus, and Cinhal. No language or time limit were applied to the search. We defined vaccination coverage as the proportion of vaccinated prisoners. There were no limitations in the search strategy regarding time period or language. Of 1079 identified studies, 28 studies were included in the review. In total, 21 reported on HBV vaccine coverage (range between 16–82%); three on HAV (range between 91–96%); two studies on combined HAV/HBV (77% in the second dose and 58% in the third); three studies on influenza vaccine (range between 36–46%), one of pneumococcal vaccine coverage (12%), and one on MMR coverage (74%). We found that data on vaccination coverage in prison inmates are scarce, heterogeneous, and do not include all relevant vaccines for this group. Current published literature indicate that prison inmates are under-immunized, particularly against HBV, influenza, MMR, and pneumococci. Strengthen immunization programs specifically for this population at risk and improvement of data record systems may contribute to better health care in prisoners.

NVNancy Vicente-Alcalde
Nancy Vicente-Alcalde
José TuellsJosé Tuells
José Tuells
CECecilia M. Egoavil
Cecilia M. Egoavil
EREsther Ruescas-Escolano
Esther Ruescas-Escolano
CACesare Altavilla
Cesare Altavilla
Pablo CaballeroPablo Caballero
Pablo Caballero
The correct immunization of the inmate population minimizes the risk of transmission of vaccine-preventable diseases in prisons. The objective of this study was to evaluate the vaccine coverage of long-term prisoners in the Spanish penitentiary system through a retrospective longitudinal study. One-thousand and five prisoners were selected, who were imprisoned from 2008 and 2018 in three Spanish prisons. Their degree of immunization was evaluated as related to hepatitis A (HAV), hepatitis B (HBV), tetanus, diphtheria, pneumococcus and seasonal flu. The state of vaccination of the prisoners with a serological diagnosis of HBV, hepatitis C (HCV) and human immunodeficiency virus (HIV) was also evaluated. The vaccination coverage obtained for hepatitis B was 52.3%, and for tetanus–diphtheria, it was 71.9%. However, for hepatitis A and pneumococcus infection, it was insignificant (<2% of the prisoners). Vaccination against seasonal flu was lower than 16%. The HCV and HIV-positive inmates were not correctly vaccinated either. The insufficient level of immunization obtained reflects the lack of interest and marginalization of this population by the penitentiary system and the health authorities. The lack of reliable records is combined with the lack of planned strategies that promote stable and well-defined programs of active vaccination.

3 December 2024 in International Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
Volker ScheerVolker Scheer
Volker Scheer
DVDavid Valero
David Valero
MTMabliny Thuany
Mabliny Thuany
Beat KnechtleBeat Knechtle
Beat Knechtle
CVCarel Viljoen
Carel Viljoen
EBEncarna Valero Burgos
Encarna Valero Burgos
Depression is an important public health issue. In the general adult population, about 6.7% are affected. Little data are available about endurance runners. We conducted a prospective survey study screening for depression using the Patient Health Questionnaire and investigating potential associated risk factors in endurance runners (≥ 21.1–42.2 km) and ultraendurance runners (≥ 42.2 km). Statistical analysis included descriptive statistics, predictive techniques, and regression analysis. A total of n = 601 runners participated (female n=222 and male n=379; mean age [SD]: 42.8 years [± 10.1]). Overall, 11.3% screened positive for major depression, particularly female runners compared to male runners (p=0.002) and endurance runners compared to ultraendurance runners (p=0.023). No significant differences were observed among performance levels (elite vs. nonelite). Mild depression was observed in 21.6% of runners. Factors associated with a higher risk for screening for major depression included age (p<0.001), particularly runners under the age of 28 years, previous self-reported history of depression (p<0.001), more frequent weekly workouts (4–5/wk; p=0.021), weeks lost to injury (p=0.022), and female sex (p=0.025). A third of endurance and ultraendurance runners screened positive for depression, highlighting the importance of creating awareness for mental health issues and potential screening for athletes and providing access to appropriate support services and education.

17 June 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
NVNancy Vicente-Alcalde
Nancy Vicente-Alcalde
TMTamara Martín-Casquero
Tamara Martín-Casquero
EREsther Ruescas-Escolano
Esther Ruescas-Escolano
José TuellsJosé Tuells
José Tuells
Tetanus is a serious and potentially fatal systemic disease, caused by the bacterium Clostridium tetani. It is estimated that 1 million cases occur worldwide annually. Immunization programs have drastically decreased tetanus in developed countries, and the sporadic cases have been linked to injecting drug users (IDUs), immunosuppressed individuals, or those older than 65 without complete vaccination. Regrettably, it is still endemic in under-developed countries. In Spain, an average of 10 cases are notified each year, especially affecting those older than 65. The present article describes a case of a 48-year-old Spanish woman, an ex-convict and IDU with infection antecedents of Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV), who was admitted to the Emergency Department of a University Hospital with cervical rigidity and trismus. In a few hours, a neurological and respiratory deterioration was observed, resulting in admittance to the intensive care unit under the suspicion of a generalized tetanus infection. The treatment included hemodynamic support and respiratory therapy, antibiotics, muscle relaxants, sedatives, and tetanus immunoglobulin. Her stay in the ICU lasted 47 days. The clinical suspicion, the antecedents of risk, and the verification of the vaccination records should provide early guidance for diagnostics and the establishment of a treatment in these cases.